uniQure N.V. (0EE0.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 06:25PM BST. Market open.
| Previous close | 4.8600 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 2,359 |
| Market cap | 1.864M |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | 0.01 |
| EPS (TTM) | 6.8870 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider Monkey13 Best Biotech Stocks To Buy Under $20
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
Simply Wall St.uniQure N.V. (NASDAQ:QURE) Just Reported And Analysts Have Been Cutting Their Estimates
It's been a sad week for uniQure N.V. ( NASDAQ:QURE ), who've watched their investment drop 12% to US$5.59 in the week...
GuruFocus.comuniQure NV CEO Matthew Kapusta Sells 27,904 Shares
uniQure NV (NASDAQ:QURE), a company specializing in gene therapy, has reported a significant insider transaction.
© 2024 Yahoo. All rights reserved.